MLTX
MoonLake Immunotherapeutics
11.70$
+2.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -0.02 | -0.95 | -1.90 | -0.87 | -1.85 | -3.04 | |
| – | 0.00 | 0.01 | 0.01 | 0.02 | 0.04 | |
| – | 0.29 | 0.33 | 0.14 | 0.12 | 0.20 | |
| – | -0.12 | 0.33 | – | – | – | |
| -0.01 | 0.12 | -0.05 | -0.13 | -0.06 | 0.31 | |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | |
| -7.77 | 0.00 | -1.10 | -0.51 | -3.27 | 3.15 | |
| – | 0.00 | – | – | – | – | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | – | |
| – | 0.00 | -0.51 | 0.00 | 0.00 | 1.13 | |
| 7.88 | 1.17 | 4.08 | 9.77 | 0.82 | 2.26 | |
| 0.09 | 0.18 | 1.07 | 8.38 | -4.31 | 2.39 | |
| -0.02 | -0.95 | -1.90 | -0.88 | -1.86 | -3.04 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.